An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
出版年份 2017 全文链接
标题
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
作者
关键词
-
出版物
Chemical Science
Volume 8, Issue 3, Pages 2241-2250
出版商
Royal Society of Chemistry (RSC)
发表日期
2016-12-16
DOI
10.1039/c6sc03862j
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy-Problems, Solutions, and Prospects
- (2016) Hiroshi Maeda et al. MICROCIRCULATION
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery
- (2015) Malin Bern et al. JOURNAL OF CONTROLLED RELEASE
- Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy
- (2015) Xiaopeng Han et al. MEDICINAL RESEARCH REVIEWS
- Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
- (2015) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Acid-Sensitive Peptide-Conjugated Doxorubicin Mediates the Lysosomal Pathway of Apoptosis and Reverses Drug Resistance in Breast Cancer
- (2015) Yuan Sheng et al. MOLECULAR PHARMACEUTICS
- Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application
- (2014) Sarah Theiner et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- A clinical update of using albumin as a drug vehicle — A commentary
- (2014) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- A Novel Class of Bis- and Tris-Chelate Diam(m)inebis(dicarboxylato)platinum(IV) Complexes as Potential Anticancer Prodrugs
- (2014) Hristo P. Varbanov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Platinum drugs binding to human serum albumin: Effect of non-steroidal anti-inflammatory drugs
- (2014) Katarzyna Wiglusz et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY
- Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
- (2014) Yao-Rong Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Unraveling the mysteries of serum albumin—more than just a serum protein
- (2014) Angelica M. Merlot et al. Frontiers in Physiology
- Hypersensitivity to oxaliplatin: clinical features and risk factors
- (2014) Marie Parel et al. BMC Pharmacology & Toxicology
- Current strategies to minimize toxicity of oxaliplatin
- (2013) Raffaele Di Francia et al. ANTI-CANCER DRUGS
- Maleimide-functionalised platinum(iv) complexes as a synthetic platform for targeted drug delivery
- (2013) Verena Pichler et al. CHEMICAL COMMUNICATIONS
- The thiol pool in human plasma: The central contribution of albumin to redox processes
- (2013) Lucía Turell et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
- (2013) Timothy C. Johnstone et al. INORGANIC CHEMISTRY
- Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: A single institution retrospective review
- (2013) FLORIAN HOHLA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Influence of Equatorial and Axial Carboxylato Ligands on the Kinetic Inertness of Platinum(IV) Complexes in the Presence of Ascorbate and Cysteine and within DLD-1 Cancer Cells
- (2013) Catherine K. J. Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection
- (2013) Anže Martinčič et al. TALANTA
- Novel tetracarboxylatoplatinum(iv) complexes as carboplatin prodrugs
- (2012) Hristo P. Varbanov et al. DALTON TRANSACTIONS
- What do we know about the reduction of Pt(IV) pro-drugs?
- (2012) Ezequiel Wexselblatt et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Unsymmetric Mono- and Dinuclear Platinum(IV) Complexes Featuring an Ethylene Glycol Moiety: Synthesis, Characterization, and Biological Activity
- (2012) Verena Pichler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity
- (2011) Chee Fei Chin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes
- (2011) Justin J. Wilson et al. INORGANIC CHEMISTRY
- An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women
- (2010) Wen Yee Chay et al. ACTA ONCOLOGICA
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells
- (2008) Dirk Garmann et al. JOURNAL OF CONTROLLED RELEASE
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started